Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist
The Right Fit Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions Patients who want a clinically-driven program rather than a vending-machine prescription Members optimizing for steady, monitored progress over months not a quick fix Not Appropriate For Personal or family history of medullary thyroid carcinoma or MEN 2 Pregnancy, breastfeeding, or planning pregnancy Active pancreatitis or untreated severe gastrointestinal disease What to Expect What to Expect Realistic timelines drawn from published clinical trials and the patients we work with
Ozempic is the most popular GLP-1 medication in the US, with the highest share of prescriptions in 2024
While manufacturer expiration dates provide conservative guidelines, properly frozen peptides often remain 80-90%+ potent well beyond stated dates when storage conditions are ideal
If that describes you, MEDVis mandatory video visit is a plus, not a drawback
Keating then pivots to the possibility of extraterrestrial life, weighing the vastness of the universe against the rarity of conditions allowing life as we know it